Total Positions
93
Quarter
2025 Q4
Top Holding
CAI (6.7%)
Top 10 Concentration
37.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 93
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CAI
CARIS LIFE SCIE...
|
Healthcare | 6.74% | 6.57% |
#1
1
Prev: #2
|
4.7 | 500,000 | 6.8% |
P
S
|
7,816,142 | $210,879,512 | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
GUARDANT HEALTH...
|
—
|
Bond/Debt | 6.15% | 8.49% |
#2
1
Prev: #1
|
2.6 | -114,600,000 | -52.2% |
P
S
|
104,854,000 | $192,312,721 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 4.14% | 2.51% |
#3
10
Prev: #13
|
1.7 | no change | no change |
P
S
|
5,210,831 | $129,306,771 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
REPLIGEN CORP
|
—
|
Bond/Debt | 3.54% | 3.02% |
#4
3
Prev: #7
|
1.4 | no change | no change |
P
S
|
101,000,000 | $110,847,500 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 3.41% | 3.67% |
#5
1
Prev: #6
|
1.4 | -128,748 | -14.6% |
P
S
|
751,534 | $106,590,067 | 2023 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 3.33% | 1.89% |
#6
10
Prev: #16
|
3.4 | 141,815 | 18.2% |
P
S
|
921,979 | $104,100,649 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
NEOGENOMICS INC
|
—
|
Bond/Debt | 2.87% | 2.58% |
#7
3
Prev: #10
|
1.1 | no change | no change |
P
S
|
100,381,000 | $89,715,519 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
NUVL
NUVALENT INC
|
Healthcare | 2.64% | 2.60% |
#8
1
Prev: #9
|
1.1 | -191,576 | -18.9% |
P
S
|
821,406 | $82,625,230 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 2.62% | 4.29% |
#9
5
Prev: #4
|
1.2 | -1,779,953 | -49.4% |
P
S
|
1,825,076 | $81,799,906 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 2.48% | 3.92% |
#10
5
Prev: #5
|
1.1 | -1,412,746 | -43.0% |
P
S
|
1,870,571 | $77,666,108 | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
IRHYTHM TECHNOL...
|
—
|
Bond/Debt | 2.33% | 2.53% |
#11
1
Prev: #12
|
1.0 | -10,000,000 | -16.1% |
P
S
|
52,000,000 | $72,800,000 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
HNGE
HINGE HEALTH IN...
|
Healthcare | 1.94% | 1.33% |
#12
13
Prev: #25
|
2.9 | 394,147 | 43.3% |
P
S
|
1,304,623 | $60,599,738 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ALGN
ALIGN TECHNOLOG...
|
Healthcare | 1.90% | 1.52% |
#13
10
Prev: #23
|
0.8 | -28,687 | -7.0% |
P
S
|
381,004 | $59,493,775 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 1.85% | — |
#14
Prev: #—
|
2.7 | 2,072,788 | no change |
NEW
|
2,072,788 | $57,955,152 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 1.76% | 2.57% |
#15
4
Prev: #11
|
0.7 | -94,130 | -7.3% |
P
S
|
1,187,859 | $54,997,872 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 1.75% | — |
#16
Prev: #—
|
2.7 | 2,188,320 | no change |
NEW
|
2,188,320 | $54,729,883 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NEO
NEOGENOMICS INC
|
Healthcare | 1.74% | 0.41% |
#17
43
Prev: #60
|
3.0 | 2,861,655 | 161.6% |
P
S
|
4,632,801 | $54,481,740 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 1.74% | 1.51% |
#18
6
Prev: #24
|
0.7 | -346,634 | -14.6% |
P
S
|
2,032,021 | $54,275,281 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 1.71% | 1.28% |
#19
7
Prev: #26
|
0.8 | -943,789 | -36.6% |
P
S
|
1,634,615 | $53,549,987 | 2023 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.68% | 0.97% |
#20
13
Prev: #33
|
2.8 | 438,878 | 52.6% |
P
S
|
1,273,935 | $52,498,861 | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
IRONWOOD PHARMA...
|
—
|
Bond/Debt | 1.61% | 2.16% |
#21
7
Prev: #14
|
0.8 | -28,735,000 | -35.0% |
P
S
|
53,405,000 | $50,467,725 | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.61% | 0.45% |
#22
33
Prev: #55
|
2.9 | 1,266,420 | 214.0% |
P
S
|
1,858,109 | $50,466,240 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 1.60% | 1.95% |
#23
8
Prev: #15
|
0.8 | -342,857 | -38.8% |
P
S
|
540,890 | $49,886,285 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 1.59% | 2.73% |
#24
16
Prev: #8
|
0.8 | -318,300 | -61.2% |
P
S
|
202,101 | $49,825,981 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 1.51% | 1.73% |
#25
6
Prev: #19
|
0.7 | -46,810 | -35.9% |
P
S
|
83,417 | $47,244,052 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
NOVOCURE LTD
|
—
|
Bond/Debt | 0.00% | 6.23% |
Sold All 😨
(Was: #3) |
0.3 | -211,364,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
N/A
KARYOPHARM THER...
|
—
|
Bond/Debt | 0.00% | 1.04% |
Sold All 😨
(Was: #30) |
0.3 | -48,482,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
GMED
GLOBUS MED INC
|
Healthcare | 0.00% | 0.85% |
Sold All 😨
(Was: #36) |
0.3 | -498,000 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
THC
TENET HEALTHCAR...
|
Healthcare | 0.00% | 0.73% |
Sold All 😨
(Was: #40) |
0.3 | -121,700 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EXAS
EXACT SCIENCES ...
|
Healthcare | 0.00% | 0.67% |
Sold All 😨
(Was: #42) |
0.3 | -414,600 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AKRO
AKERO THERAPEUT...
|
Healthcare | 0.00% | 0.67% |
Sold All 😨
(Was: #43) |
0.3 | -475,400 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ATEC
ALPHATEC HLDGS ...
|
Healthcare | 0.00% | 0.65% |
Sold All 😨
(Was: #44) |
0.3 | -1,514,604 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 0.00% | 0.59% |
Sold All 😨
(Was: #46) |
0.3 | -759,455 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.00% | 0.53% |
Sold All 😨
(Was: #49) |
0.3 | -588,700 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SRPT
SAREPTA THERAPE...
|
Healthcare | 0.00% | 0.48% |
Sold All 😨
(Was: #51) |
0.3 | -832,100 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DAWN
DAY ONE BIOPHAR...
|
Healthcare | 0.00% | 0.46% |
Sold All 😨
(Was: #54) |
0.3 | -2,181,598 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RNA
AVIDITY BIOSCIE...
|
Healthcare | 0.00% | 0.43% |
Sold All 😨
(Was: #57) |
0.3 | -331,907 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
EHC
ENCOMPASS HEALT...
|
Healthcare | 0.00% | 0.43% |
Sold All 😨
(Was: #58) |
0.3 | -113,335 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
DEXCOM INC
|
—
|
Bond/Debt | 0.00% | 0.40% |
Sold All 😨
(Was: #61) |
0.3 | -13,500,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 0.00% | 0.34% |
Sold All 😨
(Was: #63) |
0.3 | -2,750,092 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 0.00% | 0.27% |
Sold All 😨
(Was: #66) |
0.3 | -314,013 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 0.00% | 0.25% |
Sold All 😨
(Was: #67) |
0.3 | -612,841 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
RPRX
ROYALTY PHARMA ...
|
Healthcare | 0.00% | 0.19% |
Sold All 😨
(Was: #68) |
0.3 | -182,068 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
N/A
IMMUNOCORE HLDG...
|
—
|
Bond/Debt | 0.00% | 0.18% |
Sold All 😨
(Was: #69) |
0.3 | -6,828,000 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | ||
|
HTFL
HEARTFLOW INC
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #72) |
0.3 | -50,000 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-25 of 93 holdings